MacroGenics | MGNX - Market Capitalization


MacroGenics reported $257.2M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 435.86B 8.73B Aug/2026
Amgen USD 209.65B 14.21B Aug/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
Biogen USD 31.9B 5B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Eli Lilly USD 1.11T 18.32B Aug/2026
Genmab DKK 126.96B 109.86B Aug/2026
Geron USD 979M 24M Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
J&J USD 611.36B 32.21B Jun/2026
Karyopharm Therapeutics USD 221M 95M Aug/2026
MacroGenics USD 184M 82M Mar/2026
Merck USD 324.18B 6.81B Aug/2026
Pfizer USD 153.17B 14.73B Aug/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Xencor USD 1.21B 19M Aug/2026